Pam Kushner, MD, Clinical Professor, UC Irvine Medical Center, Orange, California.
J Fam Pract. 2022 Jul;71(6 Suppl):S17-S22. doi: 10.12788/jfp.0379.
At the end of the activity, participants will be able to:Summarize important findings and trends involving women and atherosclerotic cardiovascular disease (ASCVD). Characterize the multiple cardiometabolic changes that occur during menopause and the associated ASCVD risk. Discuss the challenges of assessing ASCVD risk and dyslipidemia management in women. Identify women with elevated ASCVD risk and implement guideline-recommended statin therapy.
在活动结束时，参与者将能够：总结涉及女性和动脉粥样硬化性心血管疾病（ASCVD）的重要发现和趋势。描述绝经期间发生的多种心脏代谢变化及其相关的 ASCVD 风险。讨论评估女性 ASCVD 风险和血脂异常管理的挑战。确定 ASCVD 风险升高的女性，并实施指南推荐的他汀类药物治疗。
